Previous Close | 0.0450 |
Open | 0.0450 |
Bid | 0.0350 x N/A |
Ask | 0.0400 x N/A |
Day's Range | 0.0400 - 0.0450 |
52 Week Range | 0.0150 - 0.2000 |
Volume | 43,857 |
Avg. Volume | 314,688 |
Market Cap | 4.055M |
Beta (5Y Monthly) | -0.10 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0220 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vancouver, British Columbia--(Newsfile Corp. - January 19, 2021) - CVR Medical Corp. (TSXV: CVM) (OTC: CRRVF) ("CVR Medical" or the "Company" or "we") a Canadian listed and US-based healthcare company in the medical device market is pleased to announce Michael Rhodes as Chief Executive Officer (CEO). Michael is a proven senior executive and has held several leadership positions at Fortune 100 and Fortune 500 Companies including Chief Quality Officer at Motorola Solutions Inc. ...
Vancouver, British Columbia--(Newsfile Corp. - December 15, 2020) - CVR Medical Corp. (TSXV: CVM) (OTC: CRRVF) ("CVR Medical" or the "Company" or "we") a Canadian listed and US based healthcare company in the medical device market is pleased to announce the proposed restructuring agreement between CVR Medical Corp. and CVR Global Inc. (the "Proposed Restructuring") has been preliminarily reviewed by the TSX Venture Exchange (the "Exchange"). The Exchange's final acceptance of the Proposed ...
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2020) - Â CVR Medical Corp. (TSXV: CVM) (OTC: CRRVF) ("CVR Medical" or the "Company" or "we") a Canadian listed and US based healthcare company in the medical device market announces resumption of trading on the TSX-V as of November 9, 2020. The voluntary trading halt was required by the TSX-V in response to submission of the "Restructuring Agreement". The Investment Industry Regulatory Organization ...